Maruho logo

Maruho

Asia, Tokyo, Japan, Tokyo

Description

Maruho is a healthcare service provider in dermatology area.

Investor Profile

Maruho has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maruho frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 1
Altshuler Shaham
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Maruho?

Upstream Bio

Waltham, Massachusetts, United States

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJun 2, 2022
Amount Raised: $200,000,000
Dermira

Menlo Park, California, United States

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

BiopharmaBiotechnologyPharmaceutical
Series BJun 11, 2013
Amount Raised: $35,000,000